Analyst consensus rating
Collegium Pharmaceutical Analyst Rating: Strong Buy
Direct answer
Collegium Pharmaceutical's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $49.00.
Forecast evidence checked October 17, 2026.
Get free Collegium Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $23.19
- Average price target
- $49.00
- High price target
- $60.00
- Low price target
- $43.00
- Low target gap
- +85.4%
- Target upside
- +111.3%
- High target gap
- +158.7%
- Target range width
- 73.3%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Collegium Pharmaceutical?
Collegium Pharmaceutical has a verified Strong Buy consensus. The same dataset has an average price target of $49.00.
How far are Collegium Pharmaceutical's low and high targets from the recorded price?
The low target implies +85.4%, while the high target implies +158.7%.
How many analysts are included in Collegium Pharmaceutical's consensus?
The verified consensus includes 8 analysts.
How is Collegium Pharmaceutical's target upside or downside calculated?
The average target of $49.00 is divided by the recorded price of $23.19, then one is subtracted to produce +111.3%. This does not guarantee a future return.
When was Collegium Pharmaceutical's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.